The effectiveness of anticoagulant therapy in Covid-19 associated ischemic stroke

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/4539

Full metadata record

DC Field	Value	Language
dc.contributor.author	Khamidov, Abdulakhad	-
dc.date.accessioned	2022-11-11T17:42:14Z	-
dc.date.available	2022-11-11T17:42:14Z	-
dc.date.issued	2022	-
dc.identifier.issn	2181-3485	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/4539	-
dc.description.abstract	This article analyzes the effects and efficacy of various anticoagulant agents on hemorheological indicators used in Covid-19 associated ischemic stroke and post treatment results in the early stages of the disease are presented	en_US
dc.language.iso	en	en_US
dc.publisher	Ташкент	en_US
dc.subject	Covid-19, SARS-CoV-2, ischemic stroke, activated partial thromboplastin time, D-dimer, fibrinogen, prothrombin time, heparin, enoxiparin, rivaroxaban	en_US
dc.title	The effectiveness of anticoagulant therapy in Covid-19 associated ischemic stroke	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
статия.pdf	The effectiveness of anticoagulant therapy in Covid-19 associated ischemic stroke	3.73 MB	Adobe PDF	View/Open

DSpace JSPUI